No Image Available
Description
VaxiFlu™-4 is a quadrivalent influenza vaccine designed to provide active immunization against four influenza virus strains: two influenza A subtypes (H1N1 and H3N2) and two influenza B lineages (Victoria and Yamagata). It contains inactivated (killed) virus particles, which stimulate the body's immune response without causing the disease. This vaccine is administered via intramuscular injection
Target Diseases
- Influenza (Flu)
Dosage Schedule
Children aged 9 years and older, and adults: One dose of 0.5 ml.
Possible Side Effects
- Side Effects: Injection site reactions (pain
- swelling
- redness) Headache Weakness Injection site allergic reaction Bruising
Contraindications
- History of severe allergic reactions (e.g.
- anaphylaxis) to any component of the vaccine
- including egg protein
- or following a previous dose of any influenza vaccine. Immunization should be postponed in patients with acute febrile illness.
Additional Information
- Annual revaccination with VaxiFlu™-4 is recommended due to the changing nature of influenza viruses and the duration of immunity provided by the vaccine. The vaccine should be administered intramuscularly
- preferably in the deltoid muscle for adults and older children
- or the anterolateral aspect of the thigh for younger children. Shake well before administration and inspect visually for particulate matter and discoloration prior to use.
Storage Requirements
- Store in a refrigerator at 2°C to 8°C. Do not freeze.
